Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (341-350 of 560) with videos related to

Pageof 56
Sort By:
American Journal of Obstetrics and Gynecology|December 11, 1992
The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cellsM P Boente, A Berchuck, G C Rodriguez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2016
Validation of a Novel Biomarker Panel for the Detection of Ovarian CancerFelix Leung, Marcus Q Bernardini, Marshall D Brown, et al.
Nuclear Medicine and Biology|July 1, 1997
Radioiodinated antibody targeting of the HER-2/neu oncoproteinF J Xu, Y H Yu, D S Bae, et al.
Cancer|May 15, 1996
Expression of cell regulatory proteins in ovarian borderline tumorsC van Haaften-Day, P Russell, C M Boyer, et al.
International Journal of Cancer|May 8, 2000
ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancersH Peng, F Xu, R Pershad, et al.
Lancet (London, England)|July 10, 1982
Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complementJ Ritz, S E Sallan, R C Bast, et al.
Cancer|February 21, 2008
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylationWeiwei Feng, Rebecca T Marquez, Zhen Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 25, 2006
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancerGershon Y Locker, Stanley Hamilton, Jules Harris, et al.
Frontiers in Oncology|March 23, 2013
Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer CellsYanfang Li, Tao Liu, Cristina Ivan, et al.
Gynecologic Oncology|January 11, 1992
Ploidy analysis of epithelial ovarian cancers using image cytometryA Berchuck, M P Boente, B J Kerns, et al.
Pageof 56

Showing results (341-350 of 560) with videos related to

Sort By:
Pageof 56
American Journal of Obstetrics and Gynecology|December 11, 1992
The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cellsM P Boente, A Berchuck, G C Rodriguez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2016
Validation of a Novel Biomarker Panel for the Detection of Ovarian CancerFelix Leung, Marcus Q Bernardini, Marshall D Brown, et al.
Nuclear Medicine and Biology|July 1, 1997
Radioiodinated antibody targeting of the HER-2/neu oncoproteinF J Xu, Y H Yu, D S Bae, et al.
Cancer|May 15, 1996
Expression of cell regulatory proteins in ovarian borderline tumorsC van Haaften-Day, P Russell, C M Boyer, et al.
International Journal of Cancer|May 8, 2000
ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancersH Peng, F Xu, R Pershad, et al.
Lancet (London, England)|July 10, 1982
Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complementJ Ritz, S E Sallan, R C Bast, et al.
Cancer|February 21, 2008
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylationWeiwei Feng, Rebecca T Marquez, Zhen Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 25, 2006
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancerGershon Y Locker, Stanley Hamilton, Jules Harris, et al.
Frontiers in Oncology|March 23, 2013
Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer CellsYanfang Li, Tao Liu, Cristina Ivan, et al.
Gynecologic Oncology|January 11, 1992
Ploidy analysis of epithelial ovarian cancers using image cytometryA Berchuck, M P Boente, B J Kerns, et al.
Pageof 56